No EU-US adequacy decision – what next for personal data transfers between the EEA and the United States?
Based on the current EU-US Data Privacy Framework, MEPs voted against greenlighting an adequacy decision for personal data transfers between the EU and the US. But as frustrating as that may be for US companies, what’s important is that US pharmaceutical research organisations focus on conducting Transfer Impact Assessments (TIAs) and use GDPR compliance frameworks, such as Standard Contractual Clauses, until the next steps become clearer within the EEA.